Drugs / DC/Apo-Nec
last change Dec 2005 re-read 3 minutes ago

DC/Apo-Nec

Vaccine

Developed for
melanoma
Investigated by
José Mordoh, M.D., Ph.D.

Trials 1

20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT00515983 Oct 2004 → Dec 2005 melanoma José Mordoh, M.D., Ph.D. Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as DC/Apo-Nec ClinicalTrials.gov intervention name — accepted as the source's own label NCT00515983 ↗
Modality Vaccine “with a vaccine (DC/Apo-Nec)” NCT00515983 ↗